Scopio Labs Receives FDA Clearance to Market and Sell Its X100 with Full Field Peripheral Blood Smear Application

October 21, 2020

Scopio Labs today announced they have received FDA clearance to market and sell its X100 with full field peripheral blood smear application. Full Field PBS is also available in Europe with CE mark certification granted earlier this year.

Scopio Labs notes using advanced computational photography imaging and tailored AI tools, Full Field PBS gives clinical laboratories an unprecedented ability to capture digital scans with full field view of the monolayer and feathered edge at 100X oil immersion resolution level. The Full Field PBS utilizes adaptive monolayer identification in support of long and short smears and automates the analysis process by pre-classifying 200 white blood cells (WBC), providing platelet pre-estimate, and enabling RBC morphology evaluation.

Blood is one of the most foundational gateways to health information. Roughly 120,000 laboratories worldwide conduct 600 million PBS tests annually for the global population, predominantly via manual microscopes. Even with the adoption of digital tools, today’s solutions do not showcase all required regions of interest in a PBS slide, only capturing snapshots of cells. Consequently, technologists frequently default to the manual microscope for a more detailed examination of the raw data.

“Understanding the challenges lab technicians, hematologists and hematopathologists face when evaluating blood samples containing large numbers of morphologically-unique cells in a timely fashion, we designed our solution specifically for hematology labs where we can improve quality of care, consistency of results and reduce review time,” said Scopio Labs’ CEO and Co-Founder, Itai Hayut. “We are thrilled to receive FDA clearance following the successful completion of a multi-center study, as we bring our innovative solution to laboratories around the U.S. to help improve the outcome of diagnosis and care.”

Full Field PBS is an end-to-end 100X oil immersion resolution digital microscopy solution for PBS which includes a three-slide tray and a decision support system (DSS) for pre-classification of WBC into 16 classes, red blood cell (RBC) morphology evaluations, platelet location and pre-estimate. It features adaptive monolayer identification for optimal imaging and analysis of short and long smears, including the feathered edge of the sample. With its fully digital, automated scan and image acquisition system, the Full Field PBS offers unique user experience of in-slide navigation to specified locations within a slide, all through a modern web browser interface.

“The field of microscopy is poised for transformation, and I am enthusiastic about the prospects of Scopio Labs’ innovative application,” said Michael D. Feldman, MD, PhD, Vice Chairman Clinical Services, Pathology and Laboratory Medicine at University of Pennsylvania School of Medicine. “With new digital technologies combining imaging and artificial intelligence being introduced into the laboratory, we can provide clinicians with tools that strengthen their capabilities.”

“With the first clinical-level solution that digitizes large portions of PBS, Scopio Labs is taking hematology through the next technological revolution with exponential impact to the industry, leveraging its unique computational imaging technology and specifically designed computer vision tools,” said Erez Na’aman, co-founder and CTO of Scopio Labs. “We are transforming hematology diagnostics, empowering experts and propelling the field forward.”

Earlier this year, the company closed a $16 million Series B funding round, bringing total funding to $30 million. Scopio Labs is setting its sights on transforming all hematology applications, including bone marrow aspirates (BMA) and body fluids. With a robust product development pipeline, and the ability to detect morphological events on a cellular and subcellular scale, Scopio Labs will open the door for morphology-based diagnostics, disease monitoring and treatment adjustment for various blood cancers.

Click here to experience the Scopio Full Field PBS scan.

Medical Device News Magazinehttps://infomeddnews.com
Medical Device News Magazine provides breaking medical device / biotechnology news. Our subscribers include medical specialists, device industry executives, investors, and other allied health professionals, as well as patients who are interested in researching various medical devices. We hope you find value in our easy-to-read publication and its overall objectives! Medical Device News Magazine is a division of PTM Healthcare Marketing, Inc. Pauline T. Mayer is the managing editor.

More News!

The Evolut ™ FX+ TAVR system leverages market-leading valve performance with addition of larger windows to facilitate coronary access
The study was an analysis of AstraZeneca’s Phase 2 52-Week clinical trial of tralokinumab in patients with Idiopathic Pulmonary Fibrosis (IPF). The patient data from the trial was processed with Brainomix’s e-Lung tool. The tool is uniquely powered by the weighted reticulovascular score (WRVS), a novel biomarker that incorporates reticular opacities and vascular structures of the lung.
“Since the algorithm for matching patients with donors is changing across for all organs, this was a prime time to better understand whether transplant team decisions to accept a donated organ varied by patient race and gender,” she said. “We wanted to understand how the process of receiving a transplant after listing varied by race and gender, and the combination of the two, so that steps can be taken to make that process more equitable," said Khadijah Breathett, MD.
The Mount Sinai study found that primary care physicians’ approach reflects a dearth of evidence-based guidance for lung cancer screening shared decision-making in patients with complex comorbidities
This is the first ever transplantation of a genetically engineered porcine kidney into a living human recipient.

By using this website you agree to accept Medical Device News Magazine Privacy Policy

Exit mobile version